Treatments used in the control groups included placebo, usual care, and non-TZD antidiabetic therapies.

ObjectiveTo observe the prognosis of diabetes and non-diabetic patients with coronary heart disease diffuse long lesions after sirolimus-eluting stents one year.

The present invention relates to the medicinal use of indirubin derivative, and is especially the application of indirubin derivative in preparing medicine for treating non-insulin dependent diabetes.